Interleukin Restenosis Susceptibility Test Launch Expected In 2000
This article was originally published in The Gray Sheet
Executive Summary
Interleukin Genetics is seeking a diagnostics partner to market and distribute its development-stage genetic screening test for determining a patient's susceptibility to restenosis following angioplasty and stenting.